iBio Profit Margin

iBio (IBIO) currently reports a profit margin of -9202.0% as of March 2026. That compares with -5597.87% in the prior-year period — down 64.4% year over year. That is below the Healthcare sector average of 15.58%. Use the charts on this page to explore iBio's profit margin history and peer comparisons.

iBio's profit margin decreased from -5597.87% to -9202.0% — a 64.4% year-over-year decrease (period ending March 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

iBio's profit margin of -9202.0% is lower than the Healthcare sector average of 15.58%. That is roughly 59147.6% below the sector mean. A reading lower peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.

There is no universal 'good' profit margin, but iBio's current -9202.0% should be judged against Healthcare norms (sector average: 15.58%) and against IBIO's own history. Strong, stable readings often indicate durable competitive advantage; volatile or declining ones deserve a closer look at margins and capital efficiency.

Start with the current profit margin of -9202.0%, then check the historical chart for trend and the peer comparison chart for relative positioning. The Healthcare average is 15.58%. From there, open related valuation or income-statement pages for iBio, and consider following IBIO for alerts when major investors trade the stock.